Global Chromosomal Microarray (CMA) Familial Testing Supply, Demand and Key Producers, 2023-2029

February 2023 | 107 pages | ID: GDDCFF86ACE7EN
GlobalInfoResearch

Abstracts

The global Chromosomal Microarray (CMA) Familial Testing market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Chromosomal Microarray (CMA) Familial Testing demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Chromosomal Microarray (CMA) Familial Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Chromosomal Microarray (CMA) Familial Testing that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Chromosomal Microarray (CMA) Familial Testing total market, 2018-2029, (USD Million)

Global Chromosomal Microarray (CMA) Familial Testing total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Chromosomal Microarray (CMA) Familial Testing total market, key domestic companies and share, (USD Million)

Global Chromosomal Microarray (CMA) Familial Testing revenue by player and market share 2018-2023, (USD Million)

Global Chromosomal Microarray (CMA) Familial Testing total market by Type, CAGR, 2018-2029, (USD Million)

Global Chromosomal Microarray (CMA) Familial Testing total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global Chromosomal Microarray (CMA) Familial Testing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Baylor Genetics, MedGenome Labs, Centogene, GeneDx, Quest Diagnostics, LabCorp, Lineagen, Invitae and Illumina Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Chromosomal Microarray (CMA) Familial Testing market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Chromosomal Microarray (CMA) Familial Testing Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Chromosomal Microarray (CMA) Familial Testing Market, Segmentation by Type

• Single Nucleotide Polymorphism (SNP)
• Comparative Genomic Hybridization (CGH)

Global Chromosomal Microarray (CMA) Familial Testing Market, Segmentation by Application

• Medical
• Laboratory
• Clinical
• Others

Companies Profiled:

• Baylor Genetics
• MedGenome Labs
• Centogene
• GeneDx
• Quest Diagnostics
• LabCorp
• Lineagen
• Invitae
• Illumina Inc.
• CD Genomics
• Thermo Fisher
• Agilent

Key Questions Answered

1. How big is the global Chromosomal Microarray (CMA) Familial Testing market?

2. What is the demand of the global Chromosomal Microarray (CMA) Familial Testing market?

3. What is the year over year growth of the global Chromosomal Microarray (CMA) Familial Testing market?

4. What is the total value of the global Chromosomal Microarray (CMA) Familial Testing market?

5. Who are the major players in the global Chromosomal Microarray (CMA) Familial Testing market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 Chromosomal Microarray (CMA) Familial Testing Introduction
1.2 World Chromosomal Microarray (CMA) Familial Testing Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Chromosomal Microarray (CMA) Familial Testing Total Market by Region (by Headquarter Location)
  1.3.1 World Chromosomal Microarray (CMA) Familial Testing Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States Chromosomal Microarray (CMA) Familial Testing Market Size (2018-2029)
  1.3.3 China Chromosomal Microarray (CMA) Familial Testing Market Size (2018-2029)
  1.3.4 Europe Chromosomal Microarray (CMA) Familial Testing Market Size (2018-2029)
  1.3.5 Japan Chromosomal Microarray (CMA) Familial Testing Market Size (2018-2029)
  1.3.6 South Korea Chromosomal Microarray (CMA) Familial Testing Market Size (2018-2029)
  1.3.7 ASEAN Chromosomal Microarray (CMA) Familial Testing Market Size (2018-2029)
  1.3.8 India Chromosomal Microarray (CMA) Familial Testing Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Chromosomal Microarray (CMA) Familial Testing Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Chromosomal Microarray (CMA) Familial Testing Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Chromosomal Microarray (CMA) Familial Testing Consumption Value (2018-2029)
2.2 World Chromosomal Microarray (CMA) Familial Testing Consumption Value by Region
  2.2.1 World Chromosomal Microarray (CMA) Familial Testing Consumption Value by Region (2018-2023)
  2.2.2 World Chromosomal Microarray (CMA) Familial Testing Consumption Value Forecast by Region (2024-2029)
2.3 United States Chromosomal Microarray (CMA) Familial Testing Consumption Value (2018-2029)
2.4 China Chromosomal Microarray (CMA) Familial Testing Consumption Value (2018-2029)
2.5 Europe Chromosomal Microarray (CMA) Familial Testing Consumption Value (2018-2029)
2.6 Japan Chromosomal Microarray (CMA) Familial Testing Consumption Value (2018-2029)
2.7 South Korea Chromosomal Microarray (CMA) Familial Testing Consumption Value (2018-2029)
2.8 ASEAN Chromosomal Microarray (CMA) Familial Testing Consumption Value (2018-2029)
2.9 India Chromosomal Microarray (CMA) Familial Testing Consumption Value (2018-2029)

3 WORLD CHROMOSOMAL MICROARRAY (CMA) FAMILIAL TESTING COMPANIES COMPETITIVE ANALYSIS

3.1 World Chromosomal Microarray (CMA) Familial Testing Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Chromosomal Microarray (CMA) Familial Testing Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Chromosomal Microarray (CMA) Familial Testing in 2022
  3.2.3 Global Concentration Ratios (CR8) for Chromosomal Microarray (CMA) Familial Testing in 2022
3.3 Chromosomal Microarray (CMA) Familial Testing Company Evaluation Quadrant
3.4 Chromosomal Microarray (CMA) Familial Testing Market: Overall Company Footprint Analysis
  3.4.1 Chromosomal Microarray (CMA) Familial Testing Market: Region Footprint
  3.4.2 Chromosomal Microarray (CMA) Familial Testing Market: Company Product Type Footprint
  3.4.3 Chromosomal Microarray (CMA) Familial Testing Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Chromosomal Microarray (CMA) Familial Testing Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Chromosomal Microarray (CMA) Familial Testing Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: Chromosomal Microarray (CMA) Familial Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Chromosomal Microarray (CMA) Familial Testing Consumption Value Comparison
  4.2.1 United States VS China: Chromosomal Microarray (CMA) Familial Testing Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Chromosomal Microarray (CMA) Familial Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Chromosomal Microarray (CMA) Familial Testing Companies and Market Share, 2018-2023
  4.3.1 United States Based Chromosomal Microarray (CMA) Familial Testing Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Chromosomal Microarray (CMA) Familial Testing Revenue, (2018-2023)
4.4 China Based Companies Chromosomal Microarray (CMA) Familial Testing Revenue and Market Share, 2018-2023
  4.4.1 China Based Chromosomal Microarray (CMA) Familial Testing Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Chromosomal Microarray (CMA) Familial Testing Revenue, (2018-2023)
4.5 Rest of World Based Chromosomal Microarray (CMA) Familial Testing Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based Chromosomal Microarray (CMA) Familial Testing Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Chromosomal Microarray (CMA) Familial Testing Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Chromosomal Microarray (CMA) Familial Testing Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Single Nucleotide Polymorphism (SNP)
  5.2.2 Comparative Genomic Hybridization (CGH)
5.3 Market Segment by Type
  5.3.1 World Chromosomal Microarray (CMA) Familial Testing Market Size by Type (2018-2023)
  5.3.2 World Chromosomal Microarray (CMA) Familial Testing Market Size by Type (2024-2029)
  5.3.3 World Chromosomal Microarray (CMA) Familial Testing Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Chromosomal Microarray (CMA) Familial Testing Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Medical
  6.2.2 Laboratory
  6.2.3 Clinical
  6.2.4 Others
  6.2.5 Others
6.3 Market Segment by Application
  6.3.1 World Chromosomal Microarray (CMA) Familial Testing Market Size by Application (2018-2023)
  6.3.2 World Chromosomal Microarray (CMA) Familial Testing Market Size by Application (2024-2029)
  6.3.3 World Chromosomal Microarray (CMA) Familial Testing Market Size by Application (2018-2029)

7 COMPANY PROFILES

7.1 Baylor Genetics
  7.1.1 Baylor Genetics Details
  7.1.2 Baylor Genetics Major Business
  7.1.3 Baylor Genetics Chromosomal Microarray (CMA) Familial Testing Product and Services
  7.1.4 Baylor Genetics Chromosomal Microarray (CMA) Familial Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 Baylor Genetics Recent Developments/Updates
  7.1.6 Baylor Genetics Competitive Strengths & Weaknesses
7.2 MedGenome Labs
  7.2.1 MedGenome Labs Details
  7.2.2 MedGenome Labs Major Business
  7.2.3 MedGenome Labs Chromosomal Microarray (CMA) Familial Testing Product and Services
  7.2.4 MedGenome Labs Chromosomal Microarray (CMA) Familial Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 MedGenome Labs Recent Developments/Updates
  7.2.6 MedGenome Labs Competitive Strengths & Weaknesses
7.3 Centogene
  7.3.1 Centogene Details
  7.3.2 Centogene Major Business
  7.3.3 Centogene Chromosomal Microarray (CMA) Familial Testing Product and Services
  7.3.4 Centogene Chromosomal Microarray (CMA) Familial Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 Centogene Recent Developments/Updates
  7.3.6 Centogene Competitive Strengths & Weaknesses
7.4 GeneDx
  7.4.1 GeneDx Details
  7.4.2 GeneDx Major Business
  7.4.3 GeneDx Chromosomal Microarray (CMA) Familial Testing Product and Services
  7.4.4 GeneDx Chromosomal Microarray (CMA) Familial Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.4.5 GeneDx Recent Developments/Updates
  7.4.6 GeneDx Competitive Strengths & Weaknesses
7.5 Quest Diagnostics
  7.5.1 Quest Diagnostics Details
  7.5.2 Quest Diagnostics Major Business
  7.5.3 Quest Diagnostics Chromosomal Microarray (CMA) Familial Testing Product and Services
  7.5.4 Quest Diagnostics Chromosomal Microarray (CMA) Familial Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.5.5 Quest Diagnostics Recent Developments/Updates
  7.5.6 Quest Diagnostics Competitive Strengths & Weaknesses
7.6 LabCorp
  7.6.1 LabCorp Details
  7.6.2 LabCorp Major Business
  7.6.3 LabCorp Chromosomal Microarray (CMA) Familial Testing Product and Services
  7.6.4 LabCorp Chromosomal Microarray (CMA) Familial Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.6.5 LabCorp Recent Developments/Updates
  7.6.6 LabCorp Competitive Strengths & Weaknesses
7.7 Lineagen
  7.7.1 Lineagen Details
  7.7.2 Lineagen Major Business
  7.7.3 Lineagen Chromosomal Microarray (CMA) Familial Testing Product and Services
  7.7.4 Lineagen Chromosomal Microarray (CMA) Familial Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.7.5 Lineagen Recent Developments/Updates
  7.7.6 Lineagen Competitive Strengths & Weaknesses
7.8 Invitae
  7.8.1 Invitae Details
  7.8.2 Invitae Major Business
  7.8.3 Invitae Chromosomal Microarray (CMA) Familial Testing Product and Services
  7.8.4 Invitae Chromosomal Microarray (CMA) Familial Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.8.5 Invitae Recent Developments/Updates
  7.8.6 Invitae Competitive Strengths & Weaknesses
7.9 Illumina Inc.
  7.9.1 Illumina Inc. Details
  7.9.2 Illumina Inc. Major Business
  7.9.3 Illumina Inc. Chromosomal Microarray (CMA) Familial Testing Product and Services
  7.9.4 Illumina Inc. Chromosomal Microarray (CMA) Familial Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.9.5 Illumina Inc. Recent Developments/Updates
  7.9.6 Illumina Inc. Competitive Strengths & Weaknesses
7.10 CD Genomics
  7.10.1 CD Genomics Details
  7.10.2 CD Genomics Major Business
  7.10.3 CD Genomics Chromosomal Microarray (CMA) Familial Testing Product and Services
  7.10.4 CD Genomics Chromosomal Microarray (CMA) Familial Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.10.5 CD Genomics Recent Developments/Updates
  7.10.6 CD Genomics Competitive Strengths & Weaknesses
7.11 Thermo Fisher
  7.11.1 Thermo Fisher Details
  7.11.2 Thermo Fisher Major Business
  7.11.3 Thermo Fisher Chromosomal Microarray (CMA) Familial Testing Product and Services
  7.11.4 Thermo Fisher Chromosomal Microarray (CMA) Familial Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.11.5 Thermo Fisher Recent Developments/Updates
  7.11.6 Thermo Fisher Competitive Strengths & Weaknesses
7.12 Agilent
  7.12.1 Agilent Details
  7.12.2 Agilent Major Business
  7.12.3 Agilent Chromosomal Microarray (CMA) Familial Testing Product and Services
  7.12.4 Agilent Chromosomal Microarray (CMA) Familial Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.12.5 Agilent Recent Developments/Updates
  7.12.6 Agilent Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Chromosomal Microarray (CMA) Familial Testing Industry Chain
8.2 Chromosomal Microarray (CMA) Familial Testing Upstream Analysis
8.3 Chromosomal Microarray (CMA) Familial Testing Midstream Analysis
8.4 Chromosomal Microarray (CMA) Familial Testing Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Chromosomal Microarray (CMA) Familial Testing Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Chromosomal Microarray (CMA) Familial Testing Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Chromosomal Microarray (CMA) Familial Testing Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Chromosomal Microarray (CMA) Familial Testing Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Chromosomal Microarray (CMA) Familial Testing Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Chromosomal Microarray (CMA) Familial Testing Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Chromosomal Microarray (CMA) Familial Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Chromosomal Microarray (CMA) Familial Testing Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Chromosomal Microarray (CMA) Familial Testing Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Chromosomal Microarray (CMA) Familial Testing Players in 2022
Table 12. World Chromosomal Microarray (CMA) Familial Testing Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Chromosomal Microarray (CMA) Familial Testing Company Evaluation Quadrant
Table 14. Head Office of Key Chromosomal Microarray (CMA) Familial Testing Player
Table 15. Chromosomal Microarray (CMA) Familial Testing Market: Company Product Type Footprint
Table 16. Chromosomal Microarray (CMA) Familial Testing Market: Company Product Application Footprint
Table 17. Chromosomal Microarray (CMA) Familial Testing Mergers & Acquisitions Activity
Table 18. United States VS China Chromosomal Microarray (CMA) Familial Testing Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Chromosomal Microarray (CMA) Familial Testing Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Chromosomal Microarray (CMA) Familial Testing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Chromosomal Microarray (CMA) Familial Testing Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Chromosomal Microarray (CMA) Familial Testing Revenue Market Share (2018-2023)
Table 23. China Based Chromosomal Microarray (CMA) Familial Testing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Chromosomal Microarray (CMA) Familial Testing Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Chromosomal Microarray (CMA) Familial Testing Revenue Market Share (2018-2023)
Table 26. Rest of World Based Chromosomal Microarray (CMA) Familial Testing Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Chromosomal Microarray (CMA) Familial Testing Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Chromosomal Microarray (CMA) Familial Testing Revenue Market Share (2018-2023)
Table 29. World Chromosomal Microarray (CMA) Familial Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Chromosomal Microarray (CMA) Familial Testing Market Size by Type (2018-2023) & (USD Million)
Table 31. World Chromosomal Microarray (CMA) Familial Testing Market Size by Type (2024-2029) & (USD Million)
Table 32. World Chromosomal Microarray (CMA) Familial Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Chromosomal Microarray (CMA) Familial Testing Market Size by Application (2018-2023) & (USD Million)
Table 34. World Chromosomal Microarray (CMA) Familial Testing Market Size by Application (2024-2029) & (USD Million)
Table 35. Baylor Genetics Basic Information, Area Served and Competitors
Table 36. Baylor Genetics Major Business
Table 37. Baylor Genetics Chromosomal Microarray (CMA) Familial Testing Product and Services
Table 38. Baylor Genetics Chromosomal Microarray (CMA) Familial Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Baylor Genetics Recent Developments/Updates
Table 40. Baylor Genetics Competitive Strengths & Weaknesses
Table 41. MedGenome Labs Basic Information, Area Served and Competitors
Table 42. MedGenome Labs Major Business
Table 43. MedGenome Labs Chromosomal Microarray (CMA) Familial Testing Product and Services
Table 44. MedGenome Labs Chromosomal Microarray (CMA) Familial Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. MedGenome Labs Recent Developments/Updates
Table 46. MedGenome Labs Competitive Strengths & Weaknesses
Table 47. Centogene Basic Information, Area Served and Competitors
Table 48. Centogene Major Business
Table 49. Centogene Chromosomal Microarray (CMA) Familial Testing Product and Services
Table 50. Centogene Chromosomal Microarray (CMA) Familial Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Centogene Recent Developments/Updates
Table 52. Centogene Competitive Strengths & Weaknesses
Table 53. GeneDx Basic Information, Area Served and Competitors
Table 54. GeneDx Major Business
Table 55. GeneDx Chromosomal Microarray (CMA) Familial Testing Product and Services
Table 56. GeneDx Chromosomal Microarray (CMA) Familial Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. GeneDx Recent Developments/Updates
Table 58. GeneDx Competitive Strengths & Weaknesses
Table 59. Quest Diagnostics Basic Information, Area Served and Competitors
Table 60. Quest Diagnostics Major Business
Table 61. Quest Diagnostics Chromosomal Microarray (CMA) Familial Testing Product and Services
Table 62. Quest Diagnostics Chromosomal Microarray (CMA) Familial Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Quest Diagnostics Recent Developments/Updates
Table 64. Quest Diagnostics Competitive Strengths & Weaknesses
Table 65. LabCorp Basic Information, Area Served and Competitors
Table 66. LabCorp Major Business
Table 67. LabCorp Chromosomal Microarray (CMA) Familial Testing Product and Services
Table 68. LabCorp Chromosomal Microarray (CMA) Familial Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. LabCorp Recent Developments/Updates
Table 70. LabCorp Competitive Strengths & Weaknesses
Table 71. Lineagen Basic Information, Area Served and Competitors
Table 72. Lineagen Major Business
Table 73. Lineagen Chromosomal Microarray (CMA) Familial Testing Product and Services
Table 74. Lineagen Chromosomal Microarray (CMA) Familial Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Lineagen Recent Developments/Updates
Table 76. Lineagen Competitive Strengths & Weaknesses
Table 77. Invitae Basic Information, Area Served and Competitors
Table 78. Invitae Major Business
Table 79. Invitae Chromosomal Microarray (CMA) Familial Testing Product and Services
Table 80. Invitae Chromosomal Microarray (CMA) Familial Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Invitae Recent Developments/Updates
Table 82. Invitae Competitive Strengths & Weaknesses
Table 83. Illumina Inc. Basic Information, Area Served and Competitors
Table 84. Illumina Inc. Major Business
Table 85. Illumina Inc. Chromosomal Microarray (CMA) Familial Testing Product and Services
Table 86. Illumina Inc. Chromosomal Microarray (CMA) Familial Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Illumina Inc. Recent Developments/Updates
Table 88. Illumina Inc. Competitive Strengths & Weaknesses
Table 89. CD Genomics Basic Information, Area Served and Competitors
Table 90. CD Genomics Major Business
Table 91. CD Genomics Chromosomal Microarray (CMA) Familial Testing Product and Services
Table 92. CD Genomics Chromosomal Microarray (CMA) Familial Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. CD Genomics Recent Developments/Updates
Table 94. CD Genomics Competitive Strengths & Weaknesses
Table 95. Thermo Fisher Basic Information, Area Served and Competitors
Table 96. Thermo Fisher Major Business
Table 97. Thermo Fisher Chromosomal Microarray (CMA) Familial Testing Product and Services
Table 98. Thermo Fisher Chromosomal Microarray (CMA) Familial Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Thermo Fisher Recent Developments/Updates
Table 100. Agilent Basic Information, Area Served and Competitors
Table 101. Agilent Major Business
Table 102. Agilent Chromosomal Microarray (CMA) Familial Testing Product and Services
Table 103. Agilent Chromosomal Microarray (CMA) Familial Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 104. Global Key Players of Chromosomal Microarray (CMA) Familial Testing Upstream (Raw Materials)
Table 105. Chromosomal Microarray (CMA) Familial Testing Typical Customers

List Of Figures

LIST OF FIGURES

Figure 1. Chromosomal Microarray (CMA) Familial Testing Picture
Figure 2. World Chromosomal Microarray (CMA) Familial Testing Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Chromosomal Microarray (CMA) Familial Testing Total Market Size (2018-2029) & (USD Million)
Figure 4. World Chromosomal Microarray (CMA) Familial Testing Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Chromosomal Microarray (CMA) Familial Testing Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Chromosomal Microarray (CMA) Familial Testing Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Chromosomal Microarray (CMA) Familial Testing Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Chromosomal Microarray (CMA) Familial Testing Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Chromosomal Microarray (CMA) Familial Testing Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Chromosomal Microarray (CMA) Familial Testing Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Chromosomal Microarray (CMA) Familial Testing Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Chromosomal Microarray (CMA) Familial Testing Revenue (2018-2029) & (USD Million)
Figure 13. Chromosomal Microarray (CMA) Familial Testing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Chromosomal Microarray (CMA) Familial Testing Consumption Value (2018-2029) & (USD Million)
Figure 16. World Chromosomal Microarray (CMA) Familial Testing Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Chromosomal Microarray (CMA) Familial Testing Consumption Value (2018-2029) & (USD Million)
Figure 18. China Chromosomal Microarray (CMA) Familial Testing Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Chromosomal Microarray (CMA) Familial Testing Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Chromosomal Microarray (CMA) Familial Testing Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Chromosomal Microarray (CMA) Familial Testing Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Chromosomal Microarray (CMA) Familial Testing Consumption Value (2018-2029) & (USD Million)
Figure 23. India Chromosomal Microarray (CMA) Familial Testing Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Chromosomal Microarray (CMA) Familial Testing by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Chromosomal Microarray (CMA) Familial Testing Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Chromosomal Microarray (CMA) Familial Testing Markets in 2022
Figure 27. United States VS China: Chromosomal Microarray (CMA) Familial Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Chromosomal Microarray (CMA) Familial Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Chromosomal Microarray (CMA) Familial Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Chromosomal Microarray (CMA) Familial Testing Market Size Market Share by Type in 2022
Figure 31. Single Nucleotide Polymorphism (SNP)
Figure 32. Comparative Genomic Hybridization (CGH)
Figure 33. World Chromosomal Microarray (CMA) Familial Testing Market Size Market Share by Type (2018-2029)
Figure 34. World Chromosomal Microarray (CMA) Familial Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Chromosomal Microarray (CMA) Familial Testing Market Size Market Share by Application in 2022
Figure 36. Medical
Figure 37. Laboratory
Figure 38. Clinical
Figure 39. Others
Figure 40. Chromosomal Microarray (CMA) Familial Testing Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source